UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

Annals of oncology, 2004-03, Vol.15 (3), p.511-516

2004

Volltextzugriff (PDF)

Source parameters of injection-induced microearthquakes at 9 km depth at the KTB Deep Drilling site, Germany

Bulletin of the Seismological Society of America, 1998-06, Vol.88 (3), p.815-832

1998

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i7-i9

2005

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i22-i23

2005

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for the management of cancer pain

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i83-i85

Jost, L.M.

2005

Volltextzugriff (PDF)

The modified Dunn procedure for slipped capital femoral epiphysis: The Bernese experience

Journal of children's orthopaedics, 2017-04, Vol.11 (2), p.138-146

2017

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma

Annals of oncology, 2003-07, Vol.14 (7), p.1012-1013

Jost, L M

2003

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i54-i55

2005

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i66-i68

2005

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i58-i59

2005

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i48-i49

2005

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i24-i25

2005

Volltextzugriff (PDF)

Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells

Journal of immunological methods, 1992-03, Vol.147 (2), p.153-165

1992

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of relapsed large cell non-Hodgkin's lymphoma

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i60-i61

2005

Volltextzugriff (PDF)

ESMO recommendations for the application of hematopoietic growth factors

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i80-i82

2005

Volltextzugriff (PDF)

Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies

Journal of clinical oncology, 1994-09, Vol.12 (9), p.1931-1938

1994

Volltextzugriff (PDF)

Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients : A single-center study

Oncology, 2000-08, Vol.59 (2), p.110-117

2000

Volltextzugriff (PDF)

Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomas

Annals of oncology, 1998-01, Vol.9 (1), p.51-54

1998

Volltextzugriff (PDF)

Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients

Annals of oncology, 1995-05, Vol.6 (5), p.445-451

1995

Volltextzugriff (PDF)

Fate of Contaminating t(14;18)+ Lymphoma Cells During Ex Vivo Expansion of CD34-Selected Hematopoietic Progenitor Cells

Blood, 1996-10, Vol.88 (8), p.3166-3175

1996

Volltextzugriff (PDF)

Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's disease

Annals of oncology, 1997-08, Vol.8 (8), p.785-790

1997

Volltextzugriff (PDF)

Randomized trial showing equivalent efficacy of filgrastim 5 μg/kg/d and 10 μg/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas

Journal of clinical oncology, 1997-05, Vol.15 (5), p.1730-1735

1997

Volltextzugriff (PDF)

Room-temperature electroluminescence and light detection from III-V unipolar microLEDs without p-type doping

Optica, 2023-04, Vol.10 (4), p.528

2023

Volltextzugriff (PDF)

A prospective study of risk‐adapted therapy for large cell non‐Hodgkin's lymphoma with VACOP‐B followed by high‐dose CBV and autologous progenitor cell transplantation for high‐risk patients in remission

British journal of haematology, 1999-03, Vol.104 (4), p.763-769

1999

Volltextzugriff (PDF)

Thyroiditis after treatment with interleukin-2 and interferon α-2a

British journal of cancer, 1990-07, Vol.62 (1), p.100-104

1990

Volltextzugriff (PDF)

1 – 25 von 2.168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.416)
Mit Volltextzugriff
(1.471)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(737)
Life Sciences & Biomedicine
(517)
Humans
(473)
Physical Sciences
(253)
Female
(226)
Male
(212)
Physics
(174)
Biological And Medical Sciences
(144)
Adult
(143)
Animals
(133)
Middle Aged
(131)
Medical Sciences
(111)
Meteorology & Atmospheric Sciences
(110)
Aged
(95)
Aerosols
(94)
Environmental Sciences
(92)
Environmental Sciences & Ecology
(84)
High Energy Physics - Experiment
(84)
Technology
(74)
Ophthalmology
(65)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

Source parameters of injection-induced microearthquakes at 9 km depth at the KTB Deep Drilling site, Germany

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer

ESMO Minimum Clinical Recommendations for the management of cancer pain

The modified Dunn procedure for slipped capital femoral epiphysis: The Bernese experience

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer

Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of relapsed large cell non-Hodgkin's lymphoma

ESMO recommendations for the application of hematopoietic growth factors

Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies

Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients : A single-center study

Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomas

Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients

Fate of Contaminating t(14;18)+ Lymphoma Cells During Ex Vivo Expansion of CD34-Selected Hematopoietic Progenitor Cells

Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's disease

Randomized trial showing equivalent efficacy of filgrastim 5 μg/kg/d and 10 μg/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas

Room-temperature electroluminescence and light detection from III-V unipolar microLEDs without p-type doping

A prospective study of risk‐adapted therapy for large cell non‐Hodgkin's lymphoma with VACOP‐B followed by high‐dose CBV and autologous progenitor cell transplantation for high‐risk patients in remission

Thyroiditis after treatment with interleukin-2 and interferon α-2a

Suchergebnisse filtern